Technical Analysis for VRNA - Verona Pharma plc

Grade Last Price % Change Price Change
F 15.72 -2.36% -0.38
VRNA closed down 2.36 percent on Friday, April 19, 2024, on 1.45 times normal volume.
Earnings due: May 7
*** please verify all earnings dates ***
3 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Fell Below 20 DMA Bearish -2.36%
Bollinger Band Squeeze Range Contraction -2.36%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -4.15%
20 DMA Support Bullish -4.15%
Bollinger Band Squeeze Range Contraction -4.15%
Gapped Up Strength -4.15%

   Recent Intraday Alerts

Alert Time
Lower Bollinger Band Support about 22 hours ago
60 Minute Opening Range Breakdown about 22 hours ago
20 DMA Resistance about 22 hours ago
10 DMA Resistance about 22 hours ago
Down 3% about 22 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Verona Pharma plc, a clinical stage biopharmaceutical company, researches, discovers, and develops therapeutic drugs to treat respiratory diseases primarily in the United Kingdom and North America. The company's lead product is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which is in Phase IIa clinical trial that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, and asthma. Verona Pharma plc is based in London, the United Kingdom.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Asthma Respiratory Therapy Chronic Obstructive Pulmonary Disease Respiratory Diseases Cystic Fibrosis Phosphodiesterase Lung Disorders

Is VRNA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 23.81
52 Week Low 11.83
Average Volume 437,623
200-Day Moving Average 17.01
50-Day Moving Average 16.50
20-Day Moving Average 16.21
10-Day Moving Average 16.19
Average True Range 0.67
RSI (14) 42.86
ADX 9.11
+DI 16.63
-DI 21.40
Chandelier Exit (Long, 3 ATRs) 15.23
Chandelier Exit (Short, 3 ATRs) 17.14
Upper Bollinger Bands 16.89
Lower Bollinger Band 15.53
Percent B (%b) 0.14
BandWidth 8.39
MACD Line -0.12
MACD Signal Line -0.11
MACD Histogram -0.0148
Fundamentals Value
Market Cap 1.26 Billion
Num Shares 79.9 Million
EPS -0.56
Price-to-Earnings (P/E) Ratio -28.07
Price-to-Sales 2981.17
Price-to-Book 5.16
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.88
Resistance 3 (R3) 16.91 16.55 16.68
Resistance 2 (R2) 16.55 16.26 16.54 16.62
Resistance 1 (R1) 16.14 16.08 15.96 16.11 16.55
Pivot Point 15.78 15.78 15.70 15.77 15.78
Support 1 (S1) 15.37 15.49 15.19 15.34 14.89
Support 2 (S2) 15.01 15.31 15.00 14.82
Support 3 (S3) 14.60 15.01 14.76
Support 4 (S4) 14.57